Peer-reviewedLicence not statedActa Pharmacologica Sinica
Advances in targeted therapies for pediatric tumors
4 affiliations
- 1Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058 China
- 2Nanhu Brain-computer Interface Institute, Hangzhou, 311100 China
- 3School of Medicine, Hangzhou City University, Hangzhou, 310015 China
- 4Department of Surgical Oncology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052 China
Related
- Pathomechanisms of Dermatologic Adverse Effects of Targeted Therapies in Pediatric Solid Tumors: A Narrative Review
- Recent advances in targeted therapies and immunotherapies for triple-negative breast cancer
- Targeted alpha therapy for solid tumors: biological rationale, clinical advances, and future perspectives
- Editorial: Autophagy in solid tumors and inflammation: mechanisms and therapies
- Phyllodes Tumors of the Breast in 2026: A Contemporary Narrative Review of Diagnosis, Surgical Margins, Prognosis, and Emerging Therapies
BibTeX
@article{liu2026advances,
title = {{Advances in targeted therapies for pediatric tumors}},
author = {Jia-yi Liu and Dong-liang Yang and Hai-yan Liu and Sen-feng Xiang and Ji Cao and Bo Yang and Qiao-jun He and Jin-hu Wang and Xue-jing Shao and Mei-dan Ying},
journal = {Acta Pharmacologica Sinica},
year = {2026},
month = may,
doi = {10.1038/s41401-026-01805-w},
url = {https://doi.org/10.1038/s41401-026-01805-w},
}
RIS
TY - JOUR
TI - Advances in targeted therapies for pediatric tumors
AU - Jia-yi Liu
AU - Dong-liang Yang
AU - Hai-yan Liu
AU - Sen-feng Xiang
AU - Ji Cao
AU - Bo Yang
AU - Qiao-jun He
AU - Jin-hu Wang
AU - Xue-jing Shao
AU - Mei-dan Ying
PY - 2026
DA - 2026/05/18
JO - Acta Pharmacologica Sinica
DO - 10.1038/s41401-026-01805-w
UR - https://doi.org/10.1038/s41401-026-01805-w
SN - 1671-4083
SN - 1745-7254
ER -